KENYON LAWRENCE A
SEC insider (Form 3/4/5 filer). CIK 0001230484. Chief Financial Officer at Outlook Therapeutics, Inc. (OTLK). 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in ISELIN, NJ.
Companies KENYON LAWRENCE A has filed insider reports for
- Outlook Therapeutics, Inc. (OTLK): Director, Officer, Chief Financial Officer
KENYON LAWRENCE A
CIK: 0001230484
Transaction Breakdown
Open Market Buys (P)2 (66.7%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OTLK
Outlook Therapeutics, Inc.
DirectorOfficer